PTK2 and cancer: Similar changes in infiltrating immune cell numbers and phenotypes have also been reported in models of squamous cell carcinoma (SCC) and other tumour types [41,44], suggesting that FAK plays a role in modulating anti-tumour immunity in distinct cancer contexts.